CLDF Title
Home | Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Reuters Health Information (2010-09-10): HIV no bar to hepatitis B therapy success


HIV no bar to hepatitis B therapy success

Last Updated: 2010-09-10 14:06:40 -0400 (Reuters Health)

NEW YORK (Reuters Health) - HIV infection doesn't have a negative impact on treatment of patients with hepatitis B (HBV) co-infection, French researchers report in an August 13th on-line paper in the Journal of Hepatology.

Dr. Lionel Piroth of CHU, Dijon, and colleagues came to this conclusion after retrospectively studying 246 HIV-positive and 205 HIV-negative patients who had or previously had chronic HBV infection.

Patients in the HIV group were significantly more likely to be infected with the HBV genotype A (54.8% versus 17.1%). They were also more likely to be hepatitis e antigen (HBeAg) positive (46.4% versus 32.8%).

Co-infection with hepatitis C and hepatitis delta virus was more prevalent in the HIV group. Nevertheless, they were more likely to be on HBV therapy (92.7% versus 57.1%) and to have undetectable levels of serum HBV DNA (71.0% versus 44.1%).

No difference in efficacy was seen when therapy was with tenofovir or in combination.

Excluding HBV-HCV-co-infected patients (31 HIV-positive and 6 HIV-negative), the last clinical presentation and liver fibrosis scores were similar in both groups.

HIV doesn't reduce the chances of therapeutic success, the researchers point out, and "HBV management, albeit still heterogeneous, is improving in HIV positive patients, and is now closer to that in HIV negative patients."

In fact, Dr. Piroth told Reuters Health by email, "apart from considerations directly linked to HIV therapy, chronic hepatitis B has to be assessed and managed in HIV co-infected patients as in HBV-monoinfected ones, with similar requirements. The negative impact of HIV on the evolution of untreated chronic hepatitis B is likely to disappear on efficient therapy."


J Hepatol 2010.

Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2017 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.